Oriol-Zerbe Christina, Abholz Heinz-Harald
Abteilung Allgemeinmedizin, Universitätsklinikum Düsseldorf, Heinrich-Heine University, Düsseldorf, Germany.
Eur J Gen Pract. 2007;13(1):27-34. doi: 10.1080/13814780601050541.
Guidelines/risk calculators for the primary prevention of cardiovascular disease have been developed, which could make decisions for or against therapy easier. However, it has been shown for different countries that there is still quite a discrepancy between what is done and what should be done according to guidelines/risk calculators. Usually, in Germany, neither guidelines nor risk calculators are used. On what basis, then, and with what result do German general practitioners decide for or against a treatment?
26 GPs agreed to participate in the study. From their surgeries, data from a random sample of 401 patients diagnosed with hyperlipidaemia were taken, of which 290 were eligible for the study on primary prevention. Patient risk factors were taken from their files to analyse their need for treatment using risk calculators for ERCP III (US guideline) and the European guideline. These results were compared with the treatment they received from their GPs. In semi-structured interviews, GPs were asked about their decision-making process (in four randomly chosen patients from each surgery) concerning the chosen treatment. Additionally, GPs were asked about their attitude towards guidelines/risk calculators.
89% of the patients who received treatment would also have received it according to ERCP III. According to European guidelines, only 38% of those receiving treatment need it. Concerning those not receiving treatment, 54% would not receive it according to NCEP III and 89% would not according to the European guideline. In interviews, around 75% of doctors demonstrated that they follow a multifactorial approach and a high-risk strategy. However, about 50% and 70% explicitly stated not using guidelines or risk calculators, respectively, and even among those stating that they used them, the majority were unaware of names/sources. Patient values or wishes as well as the healthcare system influenced their decisions.
German GPs seem to follow quite effectively a high-risk strategy in primary prevention, usually using a multifactorial approach, even without using risk calculators/guidelines. This kind of personalized care is also reflected in the considered importance of patient wishes and values. It is difficult to judge GPs concerning their quality of care having as a "gold standard" different risk calculators/guidelines that define whether such different populations receive treatment or not.
已制定出心血管疾病一级预防的指南/风险计算器,这能使治疗决策的做出变得更加容易。然而,不同国家的情况表明,实际所做的与根据指南/风险计算器应做的之间仍存在相当大的差异。通常在德国,既不使用指南也不使用风险计算器。那么,德国的全科医生基于什么依据、得出什么结果来决定是否进行治疗呢?
26名全科医生同意参与该研究。从他们的诊所中,抽取了401名被诊断为高脂血症患者的随机样本数据,其中290名符合一级预防研究的条件。从患者档案中获取其风险因素,使用用于ERCP III(美国指南)和欧洲指南的风险计算器来分析他们的治疗需求。将这些结果与他们从全科医生那里接受的治疗进行比较。在半结构化访谈中,询问全科医生(从每个诊所随机挑选的4名患者中)关于他们所选治疗的决策过程。此外,还询问了全科医生对指南/风险计算器的态度。
根据ERCP III,89%接受治疗的患者也会接受该治疗。根据欧洲指南,接受治疗的患者中只有38%需要治疗。对于未接受治疗的患者,根据NCEP III,54%不会接受治疗,根据欧洲指南,89%不会接受治疗。在访谈中,约75%的医生表明他们采用多因素方法和高风险策略。然而,分别约有50%和70%的医生明确表示不使用指南或风险计算器,甚至在表示使用的医生中,大多数也不知道其名称/来源。患者的价值观或愿望以及医疗保健系统影响了他们的决策。
德国全科医生在一级预防中似乎相当有效地遵循高风险策略,通常采用多因素方法,即使不使用风险计算器/指南。这种个性化护理也体现在对患者愿望和价值观的重视上。以定义不同人群是否接受治疗的不同风险计算器/指南作为“金标准”,很难评判全科医生的医疗质量。